DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 173 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,188,000 | +121.0% | 58,619 | +50.4% | 0.34% | +54.3% |
| Q2 2020 | $990,000 | -21.8% | 38,983 | -43.4% | 0.22% | -44.3% |
| Q1 2020 | $1,266,000 | -66.4% | 68,915 | -59.7% | 0.39% | -52.6% |
| Q4 2019 | $3,769,000 | +889.2% | 171,088 | +379.6% | 0.83% | +704.9% |
| Q4 2018 | $381,000 | -47.2% | 35,673 | -24.6% | 0.10% | -3.7% |
| Q3 2018 | $722,000 | +24.7% | 47,286 | 0.0% | 0.11% | +17.6% |
| Q2 2018 | $579,000 | +28.1% | 47,286 | 0.0% | 0.09% | +21.3% |
| Q1 2018 | $452,000 | -22.2% | 47,286 | -26.5% | 0.08% | -27.9% |
| Q4 2017 | $581,000 | – | 64,340 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 2,005,238 | $16,463,000 | 5.12% |
| Abingworth LLP | 945,757 | $7,755,000 | 4.53% |
| RA Capital Management | 2,428,571 | $19,939,000 | 2.86% |
| Omega Fund Management, LLC | 223,457 | $1,835,000 | 1.03% |
| DAFNA Capital Management LLC | 123,500 | $1,014,000 | 1.01% |
| Iguana Healthcare Management, LLC | 100,000 | $821,000 | 0.32% |
| Cormorant Asset Management, LP | 245,000 | $2,011,000 | 0.32% |
| Eventide Asset Management | 315,300 | $2,589,000 | 0.15% |
| AWM Investment Company, Inc. | 80,000 | $657,000 | 0.13% |
| Palo Alto Investors LP | 267,890 | $2,199,000 | 0.11% |